Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape
Stanford Cancer Center South Bay streamlines chemistry test delivery with CLSI AUTO15, boosting lab efficiency and patient care
In this guest editorial from the Clinical and Laboratory Standards Institute (CLSI), explore FDA clearance pathways and how CLSI standards can help expedite regulatory approval
Learn about the future of newborn screening in this guest editorial from Clinical and Laboratory Standards Institute
